ReviewFrontiers in oncology2022
Targeting the MDM2-p53 pathway in dedifferentiated liposarcoma.
Raymond S Traweek et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
37 papers cite it
this papercites it
ReviewFrontiers in oncology2022
Raymond S Traweek et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.